Literature DB >> 26984218

Chemotherapy-Induced Peripheral Neuropathy.

Efstathia Tzatha, Lisa M DeAngelis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26984218      PMCID： PMC5653267     

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  13 in total

1.  Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer.

Authors:  Xi Chen; Michael D Stubblefield; Christian M Custodio; Clifford A Hudis; Andrew D Seidman; Lisa M DeAngelis
Journal:  J Clin Neurophysiol       Date:  2013-04       Impact factor: 2.177

Review 2.  Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know.

Authors:  Guido Cavaletti
Journal:  J Peripher Nerv Syst       Date:  2014-06       Impact factor: 3.494

Review 3.  Management of side effects in the personalized medicine era: chemotherapy-induced peripheral neuropathy.

Authors:  Paola Alberti; G Cavaletti
Journal:  Methods Mol Biol       Date:  2014

Review 4.  Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.

Authors:  Marta Seretny; Gillian L Currie; Emily S Sena; Sabrina Ramnarine; Robin Grant; Malcolm R MacLeod; Leslie A Colvin; Marie Fallon
Journal:  Pain       Date:  2014-09-23       Impact factor: 6.961

5.  Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

Authors:  Ellen M Lavoie Smith; Herbert Pang; Constance Cirrincione; Stewart Fleishman; Electra D Paskett; Tim Ahles; Linda R Bressler; Camilo E Fadul; Chetaye Knox; Nguyet Le-Lindqwister; Paul B Gilman; Charles L Shapiro
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

6.  Chemotherapy-induced neuropathy.

Authors:  Guido Cavaletti; Paola Alberti; Barbara Frigeni; Marialuisa Piatti; Emanuela Susani
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

Review 7.  Chemotherapy-induced peripheral neurotoxicity.

Authors:  Guido Cavaletti; Paola Marmiroli
Journal:  Curr Opin Neurol       Date:  2015-10       Impact factor: 5.710

Review 8.  Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

Authors:  Dawn L Hershman; Christina Lacchetti; Robert H Dworkin; Ellen M Lavoie Smith; Jonathan Bleeker; Guido Cavaletti; Cynthia Chauhan; Patrick Gavin; Antoinette Lavino; Maryam B Lustberg; Judith Paice; Bryan Schneider; Mary Lou Smith; Tom Smith; Shelby Terstriep; Nina Wagner-Johnston; Kate Bak; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544

9.  Factors exacerbating peripheral neuropathy induced by paclitaxel plus carboplatin in non-small cell lung cancer.

Authors:  Kazuyoshi Kawakami; Takashi Tunoda; Tomomi Takiguchi; Keiko Shibata; Takayuki Ohtani; Junko Kizu; Makoto Nishio; Takeshi Horai; Toshihiro Hama; Kyoji Taguchi
Journal:  Oncol Res       Date:  2012       Impact factor: 5.574

Review 10.  Chemotherapy-induced peripheral neurotoxicity: a critical analysis.

Authors:  Susanna B Park; David Goldstein; Arun V Krishnan; Cindy S-Y Lin; Michael L Friedlander; James Cassidy; Martin Koltzenburg; Matthew C Kiernan
Journal:  CA Cancer J Clin       Date:  2013 Nov-Dec       Impact factor: 508.702
View more
  1 in total

1.  Efficacy of a topical gabapentin gel in a cisplatin paradigm of chemotherapy-induced peripheral neuropathy.

Authors:  Muhammad Shahid; Fazal Subhan; Nisar Ahmad; Robert D E Sewell
Journal:  BMC Pharmacol Toxicol       Date:  2019-08-28       Impact factor: 2.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.